Navigation Links
Qforma Appoints Kent Harris as Senior Vice President of Sales

SANTA FE, N.M., Dec. 4 /PRNewswire/ --Qforma, an advanced analytics and predictive modeling company, today announced the appointment of Kent Harris as Senior Vice President of Sales, New Business.

"Kent is highly regarded in the pharmaceutical industry and is an ideal addition to Qforma's commercial team," stated Kelly D. Myers, CEO of Qforma. "He brings nearly two decades of industry experience and an impressive record of measurable results. His success in sales operations across therapeutic areas will be a strong asset to our clients."

Harris joined Qforma from Organon Pharmaceuticals (now Schering-Plough), where he was responsible for leading a sales region comprised of 125 representatives and 11 district managers that generated $80 million in annual revenue. In his seven years as a Regional Director at Organon Pharmaceuticals, his teams consistently finished in the top 20 percent of the company.

Harris began his career with the Upjohn Company as a Sales Representative in Longview, Texas. His success in pharmaceutical field sales resulted in a promotion and a transfer to the Upjohn headquarters in Kalamazoo, MI, where he worked as a Senior Market Analyst responsible for field sales force size and structure in the U.S. and Puerto Rico. Harris was subsequently promoted to District Sales Manager, where he led a district comprised of 15 specialty representatives promoting over 25 products. He also worked for MEDai, a provider profiling company in Orlando, FL, which serviced national healthcare organizations including payers and providers, pharmaceutical companies, pharmacy benefit management and disease management companies.

"Kent's depth of knowledge in both the pharmaceutical and healthcare industries will be of great benefit to our customers and partners who will be looking for new directions and solutions in 2009," said Al Reicheg, Qforma's Senior Vice President of Commercial Operations.

About Qforma

Qforma is an advanced analytics and predictive modeling company specializing in solutions for the pharmaceutical and biotech industries. Qforma leverages the talents of physicists, mathematicians and programmers, and has developed a unique approach to quantifying large data flows with the purpose of eliminating the inefficiencies of traditional sales and marketing techniques.

Qforma is headquartered in Santa Fe, NM, with offices in Boston, MA; Bucks County, PA; and Princeton, NJ. More information is located at

    Media Contacts: 
    Lisa Haley, Qforma
    (505) 603-7596

    Jeff Hoyak, MCS Public Relations
    (800) 477-9626

Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Qforma Unveils Managed Care Optimization Solution for Pharma Marketing Executives
2. WorldHeart Appoints David Pellone Chief Financial Officer
3. Novo Nordisk Appoints New Leader of North American Business
4. Millstone Medical Outsourcing Appoints Operations Manager of New Memphis, TN, Facility
5. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
6. Resonant Medical Appoints New Vice President of Global Sales
7. Response Biomedical appoints S. Wayne Kay Chief Executive Officer
8. Stem Cell Therapy Disappoints Against Rare Kidney Ailment
9. EPI-Q Opens East Coast Office and Appoints Vice President-Business Development
10. President George W. Bush Appoints Susan G. Komen for the Cure Founder as Chief of Protocol
11. Governor Rendell Appoints Members of Chronic Care Commission as Part of Prescription for PA
Post Your Comments:
(Date:11/25/2015)... CA (PRWEB) , ... November 25, 2015 , ... According ... Vinci surgical robot is being more and more widely heralded as a breakthrough for ... da Vinci method has over traditional laparoscopic surgery is that it can greatly reduce ...
(Date:11/25/2015)... ... November 25, 2015 , ... The McHenry County law firm ... appellate decision obtained by Attorneys Francisco J. Botto and Alex C. Wimmer. Attorneys Botto ... Compensation Comm’n, 2015 IL App (2d) 130884WC. , According to court documents, Adcock testified ...
(Date:11/25/2015)... ... November 25, 2015 , ... Brillianteen, McGaw ... and learning in its 65th Anniversary Brillianteen Revue, scheduled for March 4-6, 2016. ... For 65 years, Brillianteen has been a treasured tradition for numerous families in ...
(Date:11/25/2015)... ... November 25, 2015 , ... In ... nation’s Periwinkle Pioneers, individuals and groups responsible for advancing care for pulmonary hypertension ... Pioneers, nominated by the public, will receive special recognition throughout 2016 as part ...
(Date:11/25/2015)... ... November 25, 2015 , ... Bcureful—a non-profit organization devoted ... as raising public awareness of the disorder while helping to bring expert medical ... $35,000 to bolster progress at the Tuberous Sclerosis Complex Center at Ann & ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... , Nov. 25, 2015  Amgen (NASDAQ: AMGN ... Application (BLA) with the United States ... 501, a biosimilar candidate to Humira ® (adalimumab). ... application submitted to the FDA and represents Amgen,s first ... Sean E. Harper , M.D., executive vice president of ...
(Date:11/25/2015)... 2015 On Tuesday, November 24, 2015, ... against Wright Medical Technology, Inc. for product liability ... hip implant device, awarded $11 million in favor ... trial and three days of deliberations, the jury ... defectively designed and unreasonably dangerous, and that Wright ...
(Date:11/25/2015)... Allergan plc (NYSE: AGN ) today announced that it ... State Attorney General,s Office to end the litigation ... with the Attorney General over the decision of Forest Laboratories, ... the now generic version of memantine immediate release tablets.  Under ... its counterclaims against New York , and ...
Breaking Medicine Technology: